4 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Abscess: new trials by email Literature Review of Abscess trials Research Report on Abscess
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study Cathflo (Alteplase), Saline - Intra-abdominal Abscess | Phase 3 | Terminated | The Hospital for Sick Children | 28 | 2012-03-01 | 2019-06-27 |
| A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections Doripenem, Meropenem placebo, Meropenem - Abscess, Intra-Abdominal, Abdominal Abscess | Phase 3 | Terminated | Janssen Research & Development, LLC | 41 | 2010-12-01 | 2014-07-15 |
| Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) PTK 0796, linezolid, moxifloxacin - Skin Diseases, Infectious | Phase 3 | Terminated | Paratek Pharmaceuticals Inc | 143 | 2009-04-04 | 2021-03-12 |
| Safety and Effectiveness of tPA in Intra-abdominal Abscesses Tissue Plasminogen Activator, Normal Saline - Abscess | Phase 2 / Phase 3 | Terminated | University Health Network, Toronto | 35 | 2005-07-01 | 2014-01-14 |
Abdominal Abscess (2) · Abdomen, Acute (1) · Abdominal Pain (1) · Appendicitis (1) · Cellulitis (1) · Ileus (1) · Infections (1) · Intestinal Perforation (1) · Peritonitis (1) · Rupture (1) · Skin Diseases, Infectious (1) · Wounds and Injuries (1)
Pathological Conditions, Signs and Symptoms (4) · Suppuration (4) · Infections (3) · Inflammation (3) · Pathologic Processes (3) · Cecal Diseases (1) · Connective Tissue Diseases (1) · Digestive System Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Intestinal Obstruction (1) · Intraabdominal Infections (1) · Neurologic Manifestations (1)
Tissue Plasminogen Activator (2) · 7-dimethylamino-9-(2,2-dimethylpropyl)aminomethylcycline (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Doripenem (1) · Linezolid (1) · Meropenem (1) · Moxifloxacin (1) · Saline Solution (1) · Sodium Chloride (1) · omadacycline (1)
Janssen Research & Development, LLC (1) · Paratek Pharmaceuticals Inc (1) · The Hospital for Sick Children (1) · University Health Network, Toronto (1)
Canada (2) · United States (2) · Argentina (1) · Brazil (1) · Chile (1) · Colombia (1) · Latvia (1) · Lithuania (1) · Panama (1)
Bairbre Connolly, MD (1) · Dheeraj Rajan, MD (1) · Mary West (1) · Murray Asch, MD (1)
2009 (1)